GATA6 overexpression has been observed in gastric cancer, breast cancer as well as in esophageal adenocarcinoma 7-9, while loss of GATA6 has been shown to be involved in malignant transformation of astrocytoma 10. Here, GATA6 is linked to breast cancer.